Skip to main content
. 2014 Feb 20;29(9):978–986. doi: 10.1002/gps.4088

Table 3.

Treatment-emergent adverse events with ≥5% incidence rate for patients treated with duloxetine

Event, n (%) Placebo Duloxetine p-value
N = 140 N = 151
Any event 71 (50.7) 91 (60.3) 0.125
Nausea 9 (6.4) 17 (11.3) 0.157
Headache 9 (6.4) 16 (10.6) 0.218
Constipation 5 (3.6) 14 (9.3) 0.059
Dizziness 10 (7.1) 12 (7.9) 0.828
Dry mouth 2 (1.4) 11 (7.3) 0.021
Somnolence 3 (2.1) 9 (6.0) 0.141